October 16, 2014

The Food and Drug Administration has granted approval to Esbriet (pirfenidone), as well as Ofev (nintedanib), to treat idiopathic pulmonary fibrosis — a condition in which the lungs scar over time.

August 25, 2014

Biotech company Roche will be acquiring research and pharmaceutical company InterMune for $8.3 billion, it announced over the weekend. 

May 17, 2011

An investigational drug made by InterMune improved breathing in patients with a rare and fatal lung disease, according to results of a late-stage clinical trial published online in The Lancet last week.

March 9, 2010

A Food and Drug Administration committee has recommended approval for an investigational drug for treating...

March 4, 2010

The Food and Drug Administration is reviewing a drug for treating a lung condition that...